Earth Science Tech (ETST) Cash from Operations (2011 - 2026)
Earth Science Tech (ETST) posted Cash from Operations of 885785.0 for Q1 2026, up 802.35% on a QoQ basis from 126118.0 in Q4 2025, and down 55.58% year-over-year from 1994043.0 in Q1 2025.
Earth Science Tech (ETST) Cash from Operations (2011 - 2026) Analysis & Trends
Earth Science Tech's Cash from Operations history runs 15 years deep, the most recent figure standing at 885785.0 for Q1 2026.
- Quarterly Cash from Operations fell 55.58% year-over-year to 885785.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1940863.0 (down 55.61% YoY) and the FY2026 annual result came in at 1940863.0, down 55.61% from the prior year.
- Cash from Operations was 885785.0 for Q1 2026 at Earth Science Tech, up from 126118.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1994043.0 in Q1 2025 and bottomed at 351660.0 in Q3 2022.
- A 5-year average of 375218.94 and a median of 181678.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 2391.24% — and 2024, when it soared 1869.05%.
- Earth Science Tech's Cash from Operations stood at 293517.0 in 2022, then jumped by 161.11% to 179370.0 in 2023, then jumped by 178.99% to 500430.0 in 2024, then slumped by 125.2% to 126118.0 in 2025, then jumped by 802.35% to 885785.0 in 2026.
- Business Quant data shows ETST's Cash from Operations at 885785.0 in Q1 2026, 126118.0 in Q4 2025, and 841820.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 885,785.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 885,785.00 |
| Mar 31, 2026 | 885,785.00 |
| Dec 31, 2025 | -126,118.00 |
| Dec 31, 2025 | -126,118.00 |
| Sep 30, 2025 | 841,820.00 |
| Sep 30, 2025 | 841,820.00 |
| Jun 30, 2025 | 339,376.00 |
| Jun 30, 2025 | 339,376.00 |
| Mar 31, 2025 | 1.99 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 500,430.00 |
| Dec 31, 2024 | 500,430.00 |
| Sep 30, 2024 | 926,732.00 |
| Sep 30, 2024 | 926,732.00 |
| Jun 30, 2024 | 951,185.00 |
| Jun 30, 2024 | 951,185.00 |
| Mar 31, 2024 | 898,961.00 |
| Mar 31, 2024 | 898,961.00 |
| Dec 31, 2023 | 179,370.00 |
| Dec 31, 2023 | 179,370.00 |